Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human lysosomal acid lipase

EU orphan designation number: EU/3/10/827   
Active ingredient: Recombinant human lysosomal acid lipase
Indication: Treatment of lysosomal acid lipase deficiency
Sponsor: Synageva BioPharma Ltd.
c/o Kevin Beare & Company, Forest House, 3-5 Horndean Road, Bracknell, Berkshire RG12 0XQ, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2010 Centralised Orphan - Designation EMA/OD/104/10 (2010)9540 of 17/12/2010
02/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/104/10/T/01 (2011)6292 of 30/08/2011